Discover the Argos Hemodynamic Monitor – Setting New Standards in Hemodynamic Monitoring Duomed proudly distributes the Argos Hemodynamic Monitor in Belgium and Luxembourg, offering cutting-edge accuracy and reliability for healthcare professionals. Why choose Argos? 💡 Unmatched Accuracy Unlike traditional monitors, the Argos uses multi-beat analysis to calculate cardiac output (CO) as (MAP-CVP)/SVR. This advanced approach ensures that: - Arrhythmias, vasomotor tone changes, or low cardiac output do not compromise accuracy. - It distinguishes between increases in stroke volume (SV) and systemic vascular resistance (SVR), avoiding errors caused by older algorithms that rely on pulse pressure (PP) x heart rate (HR). 🔬 Innovative Technology By analyzing 20 seconds of heartbeats and modeling the entire circulatory system, the Argos monitor provides precise results even during complex conditions. Interested in integrating the Argos Hemodynamic Monitor into your practice? Contact Duomed today! #Duomed #MedicalInnovation #ArgosMonitor #HemodynamicMonitoring #HealthcareSolutions
Have you ever wondered why our monitors are so accurate and how we differ from current competitors on the market? 🛑 Older Hemodynamic Monitors: ▪ Single beat analysis ▪ CO= PP x HR 🚫 PP increases due to SV increase, but also due to vasopressors. These algorithms cannot tell them apart. 💪 Argos Hemodynamic Monitor ▪ Multi-Beat Analysis ▪ CO= (MAP-CV)/SVR ✅ Accuracy is not impacted by arrythmia, changes in vasomotor tone, or low CO *Other hemodynamic monitors analyze one beat at a time and assume that cardiac output is proportional to pulse pressure X heart rate. This assumption has a fundamental flaw. As you know, pulse pressure will increase when you give fluids to a fluid responder, just like stroke volume. Pulse pressure will also increase if you give a vasopressor due to pulse pressure amplification. So, any monitor that assumes that Cardiac output is proportional to PP x HR can’t tell the difference between increases in stroke volume and increases in SVR. This is why the literature shows that other pulse contour technologies fail during changes in vasomotor tone. What we do is analyze 20 seconds of heart beats and create a model of the circulation, including the vascular resistance and other parameters. Then we vary the parameters until the model waveform matches the observed waveform. Once the waveforms match, then we know the resistance and we get cardiac output by taking (MAP - CVP) and dividing it by SVR. Since we model the resistance directly, our algorithm is not adversely impacted by vasomotor tone changes. Plus, because we use multiple heat beats to determine the cardiac output, our algorithm also works during arrhythmia, whereas the others do not.
Productmanager Monitoring bij Duomed Belgium
2wDit is geweldig!